CASSANDRA BAKER: Open Payments
NPI 1336701275 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$886 in 48 payments from 10 companies in 2025. Trend: 2023 $587 · 2024 $741 · 2025 $886
Food & beverage: $886
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 10 | $214 |
| ABBVIE INC. | 15 | $186 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $141 |
| Indivior Inc. | 5 | $119 |
| Alkermes, Inc. | 3 | $83 |
| Otsuka America Pharmaceutical, Inc. | 2 | $63 |
| Orexo US, Inc. | 1 | $22 |
| Exact Sciences Corporation | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Braeburn Inc. | 1 | $18 |
Products named: CAPLYTA, SUBLOCADE, MAVYRET, VRAYLAR, VIVITROL, REXULTI, Zubsolv, Cologuard Collection Kit.
Industry payments across KY — which companies pay providers there.
